Personal protective equipment for reducing the risk of COVID-19 infection among healthcare workers involved in emergency trauma surgery during the pandemic: an umbrella review protocol

Many healthcare services in low-income and middle-income international locations are inadequately resourced and will lack optimum organisation and governance, particularly regarding surgical well being methods. COVID-19 has the potential to decimate these already strained surgical healthcare providers except well being methods take stringent measures to guard healthcare staff (HCWs) from viral publicity and make sure the continuity of specialized look after sufferers. The target of this broad proof synthesis is to establish and summarise the out there literature concerning the efficacy of various private protecting gear (PPE) in lowering the danger of COVID-19 an infection in well being personnel caring for sufferers present process trauma surgical procedure in low-resource environments.
 
We’ll conduct a number of searches within the L·OVE (Dwelling OVerview of Proof) platform for COVID-19, a system that performs automated common searches in PubMed, Embase, Cochrane Central Register of Managed Trials and over 30 different sources. The search outcomes shall be offered in line with the Most popular Reporting Objects for Systematic Evaluations and Meta-Analyses circulate diagram. This assessment will preferentially contemplate systematic opinions of experimental and quasi-experimental research, in addition to particular person research of such designs, evaluating the impact of various PPE on the danger of COVID-19 an infection in HCWs concerned in emergency trauma surgical procedure. Crucial appraisal of eligible research for methodological high quality shall be carried out. Information shall be extracted utilizing the standardised knowledge extraction software in Covidence. Research will, when potential, be pooled in a statistical meta-analysis utilizing JBI SUMARI. The Grading of Suggestions, Evaluation, Growth and Analysis strategy for grading the knowledge of proof shall be adopted and a abstract of findings shall be created. Moral approval shouldn’t be required for this assessment. The plan for dissemination is to publish assessment findings in a peer-reviewed journal and current findings at high-level conferences that interact essentially the most pertinent stakeholders.

Variations in nursing residence admission between functionally outlined populations in Germany and the affiliation with high quality of well being care

Individuals want to age in place and never transfer right into a nursing residence so long as potential. The prevention of cognitive and practical impairments is possible to assist this aim. Well being providers play a key position in offering assist for underlying medical circumstances. We examined differentials in nursing residence admissions between affected person sharing networks in Germany and whether or not potential variations will be attributed to indicators of well being care provision. We carried out an ecological research utilizing knowledge of sufferers of 65 years and above from all 11 AOK statutory medical health insurance firms in Germany.

Nursing residence admissions have been noticed in a cohort of individuals turning into initially care-dependent in 2006 (n = 118,213) with a follow-up of as much as 10 years. A affected person sharing community was constructed and indicators for high quality of well being care have been calculated based mostly on knowledge of as much as 6.6 million sufferers per yr. Neighborhood detection was utilized to achieve distinct affected person populations. Analyses have been carried out descriptively and thru regression analyses to establish the variation defined by included high quality indicators. The distinction within the proportion of nursing residence admissions between recognized clusters reveals an interquartile vary (IQR) of 12.6% and the common time between onset of care-dependency and admission to a nursing residence an IQR of 10,four quarters. Included high quality indicators attributed for 40% of those variations for the proportion of nursing residence admissions and 49% for the time till nursing residence admission, respectively. Indicators of course of high quality confirmed the only highest contribution. Results of single indicators have been inconclusive.

Personal protective equipment for reducing the risk of COVID-19 infection among healthcare workers involved in emergency trauma surgery during the pandemic: an umbrella review protocol

Interprofessional well beingcare ethics training for medical and nursing college students in Germany: an interprofessional training and follow information

Early interprofessional studying amongst nursing and medical college students supplies numerous advantages for future collaboration amongst professionals, and high-quality look after sufferers. Skilled committees, thus, urge the combination of interprofessional training (IPE) in undergraduate research to attain vital sustainable enhancements in health-care follow. In Germany, IPE interventions are already applied in some health-care disciplines, however Well being-care Ethics are scarcely regarded in undergraduate training. There are, nevertheless, a number of explanation why Well being-care Ethics is especially acceptable for educating in an interprofessional format. Thus, after reviewing the authorized framework and the present curricula of each professions, an IPE course on Well being-care Ethics for medical and nursing college students was developed and applied, consisting of seven courses of 180 minutes every. Drawing on the analysis outcomes after two rounds of the course, this interprofessional training and follow information stories on challenges, obstacles and views for enchancment of an IPE course on Well being-care Ethics. It goals to supply steering for educating pioneers and innovators who implement related initiatives and to foster practice-oriented and open dialogue concerning the potentialities and limits of IPE in Well being-care Ethics.

L Wnt-5a

P0011014 One Frozen vial
EUR 543

Wnt agonist 1

B6059-10 10 mg
EUR 137
Description: Wnt agonist 1 is a small-molecule agonist of Wnt signaling pathway. The Wnt signaling pathway is an important signal transduction pathway that involved in a variety of physiological and pathological processes by regulating genes involved in cellular adhesion, proliferation, and differentiation.

Wnt agonist 1

B6059-200 200 mg
EUR 751
Description: Wnt agonist 1 is a small-molecule agonist of Wnt signaling pathway. The Wnt signaling pathway is an important signal transduction pathway that involved in a variety of physiological and pathological processes by regulating genes involved in cellular adhesion, proliferation, and differentiation.

Wnt agonist 1

B6059-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Wnt agonist 1 is a small-molecule agonist of Wnt signaling pathway. The Wnt signaling pathway is an important signal transduction pathway that involved in a variety of physiological and pathological processes by regulating genes involved in cellular adhesion, proliferation, and differentiation.

Wnt agonist 1

B6059-50 50 mg
EUR 357
Description: Wnt agonist 1 is a small-molecule agonist of Wnt signaling pathway. The Wnt signaling pathway is an important signal transduction pathway that involved in a variety of physiological and pathological processes by regulating genes involved in cellular adhesion, proliferation, and differentiation.

Wnt-6 Antibody

3570-100
EUR 316

Wnt-6 Antibody

3570-30T
EUR 146

Wnt-1 Antibody

3571-100
EUR 316

Wnt-1 Antibody

3571-30T
EUR 146

Wnt-2 Antibody

3572R-100
EUR 354

Wnt-2 Antibody

3572R-30T
EUR 146

Wnt-4 Antibody

3574R-100
EUR 316

Wnt-4 Antibody

3574R-30T
EUR 146

Wnt-1 Antibody

5754-100
EUR 316

Wnt-1 Antibody

5754-30T
EUR 146

Wnt-2 Antibody

6671-100
EUR 338

Wnt-2 Antibody

6671-30T
EUR 146

Wnt Antagonist, C59

2063-1
EUR 137

Wnt Antagonist, C59

2063-5
EUR 359

Wnt 6 antibody

20R-1649 100 ug
EUR 673
Description: Rabbit polyclonal Wnt 6 antibody

Wnt 2 antibody

20R-1650 100 ug
EUR 673
Description: Rabbit polyclonal Wnt 2 antibody

Wnt 4 antibody

20R-1651 100 ug
EUR 673
Description: Rabbit polyclonal Wnt 4 antibody

WNT-11 ELISA Kit| Mouse WNT-11 ELISA Kit

EF012834 96 Tests
EUR 689

Wnt-1 Polyclonal Antibody

ES3706-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against Wnt-1 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Wnt-16 Polyclonal Antibody

ES3836-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against Wnt-16 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

Wnt-1 Polyclonal Antibody

ES3706-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against Wnt-1 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Wnt-16 Polyclonal Antibody

ES3836-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against Wnt-16 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

Protein Wnt-3a Antibody

20-abx137444
  • EUR 704.00
  • EUR 328.00
  • EUR 230.00
  • 100 ug
  • 20 ug
  • 5 ug

Wnt-1 Polyclonal Antibody

ABP52707-003ml 0.03ml
EUR 158
Description: A polyclonal antibody for detection of Wnt-1 from Human, Mouse. This Wnt-1 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Wnt-1 at AA range: 270-350

Wnt-1 Polyclonal Antibody

ABP52707-01ml 0.1ml
EUR 289
Description: A polyclonal antibody for detection of Wnt-1 from Human, Mouse. This Wnt-1 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Wnt-1 at AA range: 270-350

Wnt-1 Polyclonal Antibody

ABP52707-02ml 0.2ml
EUR 414
Description: A polyclonal antibody for detection of Wnt-1 from Human, Mouse. This Wnt-1 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Wnt-1 at AA range: 270-350

Wnt-16 Polyclonal Antibody

ABP52837-003ml 0.03ml
EUR 158
Description: A polyclonal antibody for detection of Wnt-16 from Human, Mouse, Rat. This Wnt-16 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Wnt-16

Wnt-16 Polyclonal Antibody

ABP52837-01ml 0.1ml
EUR 289
Description: A polyclonal antibody for detection of Wnt-16 from Human, Mouse, Rat. This Wnt-16 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Wnt-16

Wnt-16 Polyclonal Antibody

ABP52837-02ml 0.2ml
EUR 414
Description: A polyclonal antibody for detection of Wnt-16 from Human, Mouse, Rat. This Wnt-16 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Wnt-16

Protein Wnt-3a Antibody

20-abx110152
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Wnt-1 antibody

STJ98451 100 µl
EUR 234
Description: Mouse monoclonal to Wnt-1.

Anti-Wnt-10b antibody

STJ98452 100 µl
EUR 234
Description: Mouse monoclonal to Wnt-10b.

Anti-Wnt-5a antibody

STJ98453 100 µl
EUR 234
Description: Mouse monoclonal to Wnt-5a.

Anti-Wnt-5a antibody

STJ98454 100 µl
EUR 234
Description: Mouse monoclonal to Wnt-5a.

Anti-Wnt-1 antibody

STJ96272 200 µl
EUR 197
Description: Rabbit polyclonal to Wnt-1.

Anti-Wnt-16 antibody

STJ96471 200 µl
EUR 197
Description: Rabbit polyclonal to Wnt-16.

Wnt-1 Polyclonal Antibody

41535-100ul 100ul
EUR 252

Wnt-1 Polyclonal Antibody

41535-50ul 50ul
EUR 187

L Wnt-3A cells

S0011001 One Frozen vial
EUR 455

Polyclonal Wnt-6 Antibody

APR00134G 0.1mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Wnt-6 . This antibody is tested and proven to work in the following applications:

Polyclonal Wnt-1 Antibody

APR00135G 0.1mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Wnt-1 . This antibody is tested and proven to work in the following applications:

Polyclonal Wnt-2 Antibody

APR00136G 0.1mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Wnt-2 . This antibody is tested and proven to work in the following applications:

Polyclonal Wnt-4 Antibody

APR00137G 0.1mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Wnt-4 . This antibody is tested and proven to work in the following applications:

Polyclonal Wnt-1 Antibody

APR00320G 0.1mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Wnt-1 . This antibody is tested and proven to work in the following applications:

Polyclonal Wnt-2 Antibody

APR00346G 0.1ml
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Wnt-2 . This antibody is tested and proven to work in the following applications:

Wnt-3a GMP, CF

PR15121CF 10 ug
EUR 649

Wnt-6 Blocking Peptide

3570BP-50
EUR 153

Wnt-1 Blocking Peptide

3571BP-50
EUR 153

Wnt-2 Blocking Peptide

3572RBP-50
EUR 153

Wnt-4 Blocking Peptide

3574BP-50
EUR 153

WNT-1, human recombinant

4754-10
EUR 283

WNT-1, human recombinant

4754-1000
EUR 5705

WNT-1, human recombinant

4754-50
EUR 729

Wnt-2, human recombinant

7599-10
EUR 387

Wnt-2, human recombinant

7599-1000
EUR 7988

Wnt-2, human recombinant

7599-50
EUR 1186

EZSolution? Wnt Antagonist, C59

9493-1
EUR 137

WNT-3a, Human Recombinant

P1194-100
EUR 615

WNT-3a, Human Recombinant

P1194-20
EUR 196

WNT-7a, Human Recombinant

P1195-100
EUR 588

WNT-7a, Human Recombinant

P1195-20
EUR 185

pcDNA3.1(+)-Wnt-10a Plasmid

PVTB00127-2a 2 ug
EUR 356

Wnt 6 Blocking Peptide

33R-10508 50 ug
EUR 349
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Wnt 6 antibody, catalog no. 20R-1649

Wnt 2 Blocking Peptide

33R-10509 50 ug
EUR 349
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Wnt 2 antibody, catalog no. 20R-1650

Wnt 4 Blocking Peptide

33R-10510 50 ug
EUR 349
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Wnt 4 antibody, catalog no. 20R-1651

Wnt-1 Recombinant Protein

40-216-0002mg 0.002 mg
EUR 259.25
Description: Wnt-1 is a secreted protein that signals through the Frizzled family of cell surface receptors and is required for normal embryonic development. Wnt-1 activation induces a complex signaling cascade that ultimately leads to the increased expression of over fifty genes. An important component of Wnt-1 signaling is the stabilization, and resulting accumulation, of the intracellular signaling protein, beta-catenin. Wnt signaling induces and maintains the transformed phenotype and, in certain embryonic cell lines, supports self renewal in the absence of significant differentiation. Elevated levels of Wnt proteins are associated with tumorigenesis and are present in numerous human breast cancers. Mature human Wnt-1 is a glycosylated protein containing 343 amino acid residues. Recombinant human Wnt-1 is a 38.4 kDa, non-glycosylated protein containing 343 amino acid residues.

Wnt-1 Recombinant Protein

40-216-001mg 0.01 mg
EUR 364.25
Description: Wnt-1 is a secreted protein that signals through the Frizzled family of cell surface receptors and is required for normal embryonic development. Wnt-1 activation induces a complex signaling cascade that ultimately leads to the increased expression of over fifty genes. An important component of Wnt-1 signaling is the stabilization, and resulting accumulation, of the intracellular signaling protein, beta-catenin. Wnt signaling induces and maintains the transformed phenotype and, in certain embryonic cell lines, supports self renewal in the absence of significant differentiation. Elevated levels of Wnt proteins are associated with tumorigenesis and are present in numerous human breast cancers. Mature human Wnt-1 is a glycosylated protein containing 343 amino acid residues. Recombinant human Wnt-1 is a 38.4 kDa, non-glycosylated protein containing 343 amino acid residues.

WNT-7A Recombinant Protein

40-577-0003mg 0.003 mg
EUR 259.25
Description: Wnt-7a belongs to the Wnt family of signaling proteins that play a key role in maintaining the integrity of embryonic and adult tissues. It is expressed in placenta, kidney, testis, uterus, fetal lung and fetal and adult brain. Most Wnt proteins can signal though a mechanism called the canonical Wnt pathway, in which Wnt proteins bind to and activate seven-pass transmembrane receptors of the Frizzled family ultimately leading to the disruption of β-Catenein degradation. Intracellular accumulation of β-Catenin increases translocation of the protein into the nucleus where it binds to TCF/LEF transcription factors and induces the expression of numerous genes. Increased Wnt/β-Catenein signaling is associated with tumorigenesis in a diverse set of human cancers. However, Wnt-7a/Frizzled-9 signaling has been shown to act as a tumor suppressor in non-small cell lung cancers. Recombinant human Wnt-7a is a 35.5 kDa glycoprotein containing 318 amino acids. Due to glycosylation, Wnt-7a migrates between 40-55 kDa by SDS-PAGE gel under unreduced conditions.

WNT-7A Recombinant Protein

40-577-0015mg 0.015 mg
EUR 364.25
Description: Wnt-7a belongs to the Wnt family of signaling proteins that play a key role in maintaining the integrity of embryonic and adult tissues. It is expressed in placenta, kidney, testis, uterus, fetal lung and fetal and adult brain. Most Wnt proteins can signal though a mechanism called the canonical Wnt pathway, in which Wnt proteins bind to and activate seven-pass transmembrane receptors of the Frizzled family ultimately leading to the disruption of β-Catenein degradation. Intracellular accumulation of β-Catenin increases translocation of the protein into the nucleus where it binds to TCF/LEF transcription factors and induces the expression of numerous genes. Increased Wnt/β-Catenein signaling is associated with tumorigenesis in a diverse set of human cancers. However, Wnt-7a/Frizzled-9 signaling has been shown to act as a tumor suppressor in non-small cell lung cancers. Recombinant human Wnt-7a is a 35.5 kDa glycoprotein containing 318 amino acids. Due to glycosylation, Wnt-7a migrates between 40-55 kDa by SDS-PAGE gel under unreduced conditions.

Wnt-9b Recombinant Protein

40-653 5 ug
EUR 259.25
Description: Formerly known as Wnt-15 or Wnt-14b, Wnt-9b is a secreted glycoprotein belonging to the Wnt family of signaling proteins that are critically involved in maintaining the integrity of both embryonic and adult tissues. Wnt-9b is primarily expressed in adult kidneys and during late embryogenesis, and shares with other Wnt family members the same highly conserved lipid-modified, cysteine-rich domain essential for cell signaling. As is true for most Wnt family members, Wnt-9b functions through the biochemical process known as the canonical Wnt pathway. In this process, Wnt proteins bind to and activate seven-pass transmembrane receptors of the Frizzled family, and ultimately results in the disruption of β-catenin degradation. Intracellular accumulation of β-catenin increases translocation of the protein into the nucleus, where it binds to TCF/LEF transcription factors to promote the expression of numerous genes. In this manner, Wnt signaling induces and maintains transformed phenotype, and, in certain embryonic cell lines, supports self-renewal in the absence of significant differentiation. While increased Wnt/β-catenin signaling is associated with tumorigenesis in a diverse set of human cancers, lack of Wnt signaling disrupts transcriptional activation of tumor suppressor genes, and has been shown to result in neoplastic transformation, oncogenesis, and human degenerative diseases. Altered Wnt-9b expression has been shown to result in the underdevelopment of the kidneys, and incomplete lip and cleft fusion in mice. Recombinant Human Wnt-9b is a monomeric glycoprotein containing 335 amino acid residues and has a calculated molecular weight of 36.9 kDa. Due to glycosylation, Recombinant Human Wnt-9b migrates at an apparent molecular weight of approximately 49-54 kDa by SDS-PAGE analysis under non-reducing conditions.

WNT-3A Recombinant Protein

40-700 2 ug
EUR 259.25
Description: Wnt-3a belongs to the Wnt family of signaling proteins that play a key role in maintaining the integrity of embryonic and adult tissues. Expression of Wnt-3a occurs primarily along the dorsal midline across overlapping regions of the Central Nervous System (CNS). Wnt-3a signaling is essential for various morphogenetic events, including embryonic patterning, cell determination, cell proliferation, CNS development, and cytoskeletal formation. Like other members of this family, Wnt-3a contains a highly conserved lipid-modified, cysteine-rich domain that is essential for cell signaling. During a biochemical process called the canonical Wnt pathway, Wnt family members bind to and activate, seven-pass transmembrane receptors of the Frizzled family, ultimately leading to the disruption of β-catenin degradation. Intracellular accumulation of β-catenin increases translocation of the protein into the nucleus, where it binds to TCF/LEF transcription factors to promote gene expression. Lack of Wnt signaling disrupts transcriptional activation of tumor suppressor genes, and has been shown to result in neoplastic transformation, oncogenesis, and human degenerative diseases. Recombinant Murine Wnt-3a is a monomeric glycoprotein containing 334 amino acid residues. Due to glycosylation, the Murine Wnt-3a migrates at an apparent molecular weight of approximately 38.0-41.0 kDa by SDS-PAGE analysis under non-reducing conditions.

Protein Wnt-10a (WNT10A) Antibody

20-abx301908
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Protein Wnt-4 (WNT4) Antibody

20-abx302751
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Recombinant Human WNT-1 Protein

PROTP04628 10ug
EUR 317
Description: Wnt-1 is a secreted protein that signals through the Frizzled family of cell surface receptors and is required for normal embryonic development. Wnt-1 activation induces a complex signaling cascade that ultimately leads to the increased expression of over fifty genes. An important component of Wnt-1 signaling is the stabilization, and resulting accumulation, of the intracellular signaling protein, β-catenin. Wnt signaling induces and maintains the transformed phenotype and, in certain embryonic cell lines, supports self renewal in the absence of significant differentiation. Elevated levels of Wnt proteins are associated with tumorigenesis and are present in numerous human breast cancers. Mature human Wnt-1 is a glycosylated protein containing 343 amino acid residues. Recombinant human Wnt-1 is a 38.4 kDa, non-glycosylated protein containing 343 amino acid residues.

Recombinant Human WNT-7A Protein

PROTO00755-1 15ug
EUR 317
Description: Wnt-7a belongs to the Wnt family of signaling proteins that play a key role in maintaining the integrity of embryonic and adult tissues. It is expressed in placenta, kidney, testis, uterus, fetal lung and fetal and adult brain. Most Wnt proteins can signal though a mechanism called the canonical Wnt pathway, in which Wnt proteins bind to and activate seven-pass transmembrane receptors of the Frizzled family ultimately leading to the disruption of β-Catenein degradation. Intracellular accumulation of β-Catenin increases translocation of the protein into the nucleus where it binds to TCF/LEF transcription factors and induces the expression of numerous genes. Increased Wnt/β-Catenein signaling is associated with tumorigenesis in a diverse set of human cancers. However, Wnt-7a/Frizzled-9 signaling has been shown to act as a tumor suppressor in non-small cell lung cancers. Recombinant human Wnt-7a is a 35.5 kDa glycoprotein containing 318 amino acids. Due to glycosylation, Wnt-7a migrates between 40-55 kDa by SDS-PAGE gel under unreduced conditions

Protein Wnt-2 (WNT2) Antibody

abx122394-100ug 100 ug
EUR 391

Protein Wnt-7b (WNT7B) Antibody

abx122911-100ug 100 ug
EUR 391

Protein Wnt-4 (WNT4) Antibody

20-abx116674
  • EUR 732.00
  • EUR 398.00
  • 150 ul
  • 50 ul

Protein Wnt-7a (WNT7A) Antibody

20-abx116675
  • EUR 732.00
  • EUR 398.00
  • 150 ul
  • 50 ul

Protein Wnt-3a (WNT3A) Antibody

abx117009-100ug 100 ug
EUR 467

Protein Wnt-5a (Wnt5a) Antibody

abx117221-100ug 100 ug
EUR 467

Protein Wnt-3a (WNT3A) Antibody

20-abx136135
  • EUR 495.00
  • EUR 704.00
  • EUR 356.00
  • 100 ul
  • 200 ul
  • 50 ul

Protein Wnt-5a (Wnt5a) Antibody

20-abx123422
  • EUR 592.00
  • EUR 857.00
  • EUR 411.00
  • 100 ul
  • 200 ul
  • 50 ul

Protein Wnt-6 (WNT6) Antibody

20-abx124423
  • EUR 411.00
  • EUR 592.00
  • 100 ul
  • 200 ul

Protein Wnt-3a Antibody (Biotin)

20-abx105841
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Protein Wnt-3a Antibody (FITC)

20-abx107257
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Protein Wnt-3a Antibody (HRP)

20-abx108677
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Protein Wnt-4 (WNT4) Antibody

abx036970-100ug 100 ug
EUR 391

Protein Wnt-5a (WNT5A) Antibody

abx012361-100ul 100 ul
EUR 411
Sufferers with oral well being issues typically attend GPs as an alternative of dentists, notably in rural areas. There was little analysis exploring challenges in offering oral well being care in city normal follow. A cross-sectional survey of GPs in Larger Western Sydney explored their experiences, data, confidence, and their oral well being academic wants. Descriptive statistics and content material evaluation was undertaken. Forty-nine GPs reported expertise of a variety of oral well being shows. Roughly 60% have been assured to undertake oral well being examinations and decide the reason for acute toothache. Though 87% have been assured offering preventative oral well being recommendation, most didn’t embody this in routine well being assessments.